COMMUNIQUÉS West-GlobeNewswire

MedDay annonce un symposium satellite et présente des données supplémentaires sur le MD1003 dans la sclérose en plaques progressive lors du congrès ECTRIMS-ACTRIMS

26/10/2017 - 07:00

MedDay annonce un symposium satellite et présente des données supplémentaires sur le MD1003 dans la sclérose en plaques progressive lors du congrès ECTRIMS-ACTRIMS Présence de MedDay au stand D30 lors du congrès Paris, [...]

Probiodrug to Present Data from its Phase 2a SAPHIR Study at International Alzheimer's Disease Conference

26/10/2017 - 07:00

Probiodrug to Present Data from its Phase 2a SAPHIR Study at International Alzheimer's Disease Conference Prof. Philipp Scheltens, Principal Investigator of the study, to present at Clinical Trials on Alzheimer's [...]

ZAGENO on Growth Trajectory - Startup Becoming #1 Online Marketplace for Life Science Research Products; Raises $8 Million

25/10/2017 - 21:40

BOSTON, Mass., USA, and BERLIN, GERMANY, Oct. 25, 2017 (GLOBE NEWSWIRE) -- ZAGENO Inc. , announces successful Series A investment of $8 Million US Dollars led by Capnamic Ventures , with Grazia Equity , lead investor in [...]

NOTICE IN RELATION TO THE CONVERTIBLE BONDS DUE MAY 2020

25/10/2017 - 18:40

REGULATED INFORMATION GHENT, Belgium, 25 October 2017 (6.30 pm CEST) - Ablynx NV [Euronext Brussels: ABLX, NASDAQ: ABLX] , a late-stage clinical biopharmaceutical company utilising its proprietary Nanobody® platform to [...]

Enzymatica AB: Bulletin from extraordinary general meeting in Enzymatica AB (publ)

25/10/2017 - 18:00

Enzymatica Bulletin from EGM Oct 25 2017 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]

GUERBET : Chiffre d'affaires au 30 septembre 2017

25/10/2017 - 17:48

597,4 M€ à taux de change constant : +5,1% Niveau d'activité conforme aux anticipations Villepinte, le 25 octobre 2017 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l' [...]

GUERBET : Revenue at September 30, 2017

25/10/2017 - 17:48

€597.4 million at constant exchange rates: +5.1% Level of activity in line with expectations Villepinte, October 25, 2017 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical [...]

Advance Notice: EastPharma Ltd Sales Update Announcement for the period 30 September 2017

25/10/2017 - 17:43

EASTPHARMA LTD. London, 25 October 2017 - EastPharma (EAST LI) informs that it will be releasing its 9M 2017 sales performance and a review of its main subsidiary DEVA Holding's unaudited financial statements for the [...]

Novartis confirms leadership in multiple sclerosis (MS) with scientific advancements and new data presented at ECTRIMS

25/10/2017 - 17:30

Full data from the pivotal Phase III PARADIGMS study of Gilenya ® (fingolimod) in pediatric MS will be presented for the first time With 54 accepted abstracts, Novartis presence spans from new siponimod (BAF312) data in [...]

AbCheck and Molecular Templates Announce Collaboration to Discover Therapeutic Oncology Leads

25/10/2017 - 16:11

Plzen, Czech Republic, and Austin, TX, USA, October 25, 2017 - AbCheck s.r.o., a technology company focusing on the discovery and optimization of high-quality human antibodies, and Molecular Templates Inc., a publicly [...]

Medtronic Announces First Economic Analysis Demonstrating Benefits of Professional CGM in People with Type 2 Diabetes

25/10/2017 - 15:00

DUBLIN - October 25, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced data from the first economic analysis conducted on the use of professional continuous glucose monitoring ( [...]

Summit Therapeutics plc : Grant of share options

25/10/2017 - 15:00

Summit Therapeutics plc ('Summit' or the 'Company') GRANT OF SHARE OPTIONS TO DIRECTORS, PDMRS AND EMPLOYEES AND GRANT OF RESTRICTED STOCK UNITS TO NON-EXECUTIVE DIRECTORS Oxford, UK, 25 October 2017 - Summit [...]

CapsoVision, Inc. Announces CE Mark for the Use of CapsoCam Plus Capsule Endoscopy System in Patients Ages 2 and Above

25/10/2017 - 14:00

Award-winning technology provides 360º imaging, eliminates need for receiver equipment during examination SARATOGA, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Today Silicon Valley-based CapsoVision, Inc. announced CE [...]

SUSPENSION OF TRADING IN ABLYNX SHARES ON EURONEXT BRUSSELS

25/10/2017 - 13:09

REGULATED INFORMATION GHENT, Belgium, 25 October 2017 (1 pm CEST) - Trading in the shares of Ablynx NV [Euronext Brussels: ABLX; OTC: ABYLY] was suspended at the request of the Company on 25 October 2017 as from 1 pm [...]

Shire Receives Orphan Drug Designation for Gene Therapy Candidate SHP654 (BAX 888) for the Treatment of Hemophilia A

25/10/2017 - 13:00

Shire Receives Orphan Drug Designation for Gene Therapy Candidate SHP654 (BAX 888) for the Treatment of Hemophilia A SHP654 investigational new drug (IND) application accepted by the FDA Lexington, MA - October 25, 2017 [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

25/10/2017 - 09:00

FIT Biotech Oy Company release October 25, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Ambu acquires Invendo Medical and enters market of 70 million gastro procedures annually

25/10/2017 - 08:33

Ambu fast-forwards it's single-use endoscopy business. The purchase price of EUR 225 million includes contingent payments of up to EUR 110 million. Today, Ambu has acquired Invendo Medical GmbH. Invendo Medical is a [...]

CellaVision AB: Interim report January - September 2017

25/10/2017 - 08:20

An in-between quarter though with stronger market presence as well as product sales approval in the USA 1 juli-30 september 2017 1 januari-30 september 2017 Net sales decreased by 10 % to SEK 61.3 million (68.3) Organic [...]

Nexstim raises EUR 1.75 million via a directed issue of new shares to London-based investor City Financial - Funds to be used to support beginning the commercialisation of its NBT® system

25/10/2017 - 08:00

Company announcement, Helsinki, 25 October 2017 at 9:00 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]